Financial Outcomes of “Bagging” Oncology Drugs Among Privately Insured Patients With Cancer

This cohort study examines the difference in per-patient per-month costs between drugs distributed under “bagging,” a drug delivery model that requires patients to obtain physician-administered medications via pharmacies, and traditional buy-and-bill practice.

Detalles Bibliográficos
Autores principales: Shih, Ya-Chen Tina, Xu, Ying, Yao, James Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485724/
https://www.ncbi.nlm.nih.gov/pubmed/37676663
http://dx.doi.org/10.1001/jamanetworkopen.2023.32643
Descripción
Sumario:This cohort study examines the difference in per-patient per-month costs between drugs distributed under “bagging,” a drug delivery model that requires patients to obtain physician-administered medications via pharmacies, and traditional buy-and-bill practice.

Ejemplares similares